Around the web ×2
Quick answers
Who is Anthony Iacovone?
A co-founder of BioSymetrics, the New York-based drug discovery company with a team cluster in Toronto. BioSymetrics' team page lists him as a co-founder, and an October 2022 release announcing the company's partnership with Deerfield Management called him co-founder and CEO.
What is Anthony Iacovone's current role?
When checked in September 2026, BioSymetrics' team page described him as a BioSymetrics co-founder and as CEO and co-founder of Veylan. An April 2025 release on the closing of BioSymetrics' merger with Renovaro called him CEO of BioSymetrics. Renovaro renamed itself Lunai Bioworks in August 2025.
What did Anthony Iacovone do before BioSymetrics?
Patch reported in April 2017 that he co-founded and launched the mobile advertising technology company AdTheorent in 2011 and was its CEO. The article covered his purchase of the New Britain Bees baseball club.
Where has Anthony Iacovone talked about AI in healthcare?
He appeared as CEO of BioSymetrics on episode 48 of The Business of Healthcare Podcast from UT Dallas's Naveen Jindal School of Management, published 8 November 2019 and hosted by Dr. Bob Kaiser. The episode covered AI and machine learning in drug discovery, clinical diagnostics and value-based care.